Marex (MRX) EBITDA Margin (2023 - 2026)

Marex (MRX) has reported EBITDA Margin for 4 consecutive years, with 15.22% the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBITDA Margin fell 1976.0% year-over-year to 15.22%; the trailing twelve-month figure through Jun 2026 stood at 15.84% (down 5656.0% YoY), and the FY2025 full-year result was 17.22%, down 203.0% from the prior year.
• EBITDA Margin slipped to 15.22% in Q2 2026 per MRX's latest filing, from 9.2% in the prior quarter.
• Across five years, EBITDA Margin topped out at 83.12% in Q1 2025 and bottomed at 20.68% in Q3 2025.
• Historically, EBITDA Margin has averaged 12.04% across 4 years, with a median of 4.54% in 2025.
• The sharpest annual moves came in 2025 and 2026: EBITDA Margin soared 6461 bps in 2025, then tumbled 9232 bps in 2026.
• Over 4 years, EBITDA Margin stood at 5.87% in 2023, then soared by 1047 bps to 55.53% in 2024, then sank by 137 bps to 20.54% in 2025, then rose by 26 bps to 15.22% in 2026.
• According to Business Quant data, EBITDA Margin over the past three periods registered 15.22%, 9.2%, and 20.54% for Q2 2026, Q1 2026, and Q4 2025 respectively.